The chart solidifies you what you already know: Biotech stocks are off to a blistering start in 2014.
The iShares Nasdaq Biotechnology Index ETF (IBB) is trouncing the S&P 500 through the first three weeks of the year.
IBB data by YCharts
It's hard to imagine, but biotech stocks are starting off 2014 stronger than they did in 2013.
Here's the same IBB vs. S&P 500 comparison as above, but looking at the first 20 calendar days of 2013:
The top-performing biotech and drug stocks year to date, according to S&P CapitalIQ:
Intercept Pharma (ICPT) +329%
Rexahn Pharma (RNN)+116%
Neurocine Biosciences (NBIX) +110%
CorMedix (CRMD) +98%
Cell Therapeutics (CTIC) +91%